Biotechnology Law Report invites the submission of original manuscripts covering all aspects of biotechnology law. Send manuscripts to Managing Editor Steven J. Zweig. Please see email directly below.
Articles should be submitted in electronic form, as e-mail attachments to email@example.com
Please specify in the text of the e-mail the word processing format used in creating the manuscript. Microsoft Word is preferred.
Use of English Language
All submissions must be in English. Appropriate use of English is a requirement for review and publication in Biotechnology Law Report. To support non-native speakers, Mary Ann Liebert, Inc., has partnered with Editage to provide language editing and translation services for a fee prior to official submission. To learn more about the services, please visit the Liebert Author Services website. Please note that employing the use of such services is not mandatory and using it, or any other language editing service, does not guarantee the acceptance of any paper. All submissions are subject to peer review.
SPECIAL OPEN ACCESS publishing option -- Contact: firstname.lastname@example.org
Using Blue Book format, please generate footnotes cited by superscript reference numerals throughout the text. We reserve the right to modify style to conform to the Journal’s overall style. Suggested readings or lists of other source materials may also be included in a final footnote.
The author must obtain permission to reproduce from any copyrighted material. Written permission must be obtained from the original copyright holder (generally the publisher) of the journal or book concerned. An appropriate credit line and copyright notice should be included and a full citation should be included in the reference list.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Biotechnology Law Report is published six times a year by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101.
Mary Ann Liebert, Inc., publishers has partnered with Editage and Impact Science to provide a dynamic suite of specialized editorial services to ensure your manuscript has the impact it deserves.
Make Your Manuscript Submission-Ready
English Language Editing Services
Our pre-submission English Language Editing Services pair you with a highly qualified native English-speaking editor within your specific field of study. Dedicated support includes a detailed review of grammar, punctuation, terminology, and spelling, as well as an intensive edit for organization. We also offer post-submission support where needed.
English-Language Translation with Editing Services
Write your paper in your native language and our expert team will provide you with a translation that meets international publication standards while preserving the science and accuracy of your manuscript. Our translators and editors offer subject-specific expertise and editing skills to ensure that your manuscript conveys every nuance of your research to a global audience.
Accelerate Your Research Impact
Research Promotion Services
Amplify your research with engaging infographics, video abstracts, plain language summaries, and more to ensure your manuscript is discovered, read, and cited. Our specialized team of communication experts, scientists, and designers will transform your research into impactful text, graphical, and audio-visual formats that resonate with a wider audience and increase engagement.
Visit our Author Services portal now for more information and to get started!
All Editage services are fee-based services that authors can opt-into as an added author benefit to amplify the readability, visibility, findability, and shareability of their work.
Publishing Open Access
Open Access enables you to publish your work under a Creative Commons (CC-BY) copyright license in our esteemed hybrid journals. Publishing Open Access makes your article immediately available to read globally, increasing the visibility and potential impact of your research.
Benefits of Publishing Open Access:
- Maximum visibility: open access articles are freely available online upon publication with no subscription needed
- Authors retain copyright, allowing broad dissemination of research
- Articles can be freely shared in repositories and research networks without restrictions
- Automatic submission to PubMed Central and PMC mirror sites, when applicable*
- Open access articles are listed with an OA icon in journal tables of content (TOC), TOC email alerts, and in marketing announcements
Choosing Open Access
Once your article has been accepted for publication, you will receive an email with information on how to order open access. An Article Processing Charge (APC) is required to cover the cost of Open Access publication and article processing. Once payment is received your article will be published Open Access.
Copyright and Licensing
- The CC BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- The CC BY-NC license permits any noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
*Please note that PubMed Central, not the Publisher, has sole control over when the paper is made live on PMC.
You can find out more about additional publication services, browse our portfolio of fully open access journals, read FAQs, and more on our Liebert Open Access page or by contacting email@example.com.